Skip to Main Content
Contributors
++

KRISTIE A. BLUM MD, Assistant Professor of Internal Medicine, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

++

BRETT THOMAS BRINKER MD, Hematology/Oncology Fellow, Division of Hematology/ Oncology, Northwestern University Feinberg School of Medicine, Chicago, Ilinois, USA

++

JOHN C. BYRD MD, Associate Professor of Medicine and Medicinal Chemistry, D. Warren Brown Professor in Leukemia Research, Director of Hematologic Malignancies, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

++

BRUCE D. CHESON MD, Professor of Medicine, Division of Hematology/Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA

++

BERTRAND COIFFIER MD, Professor of Haematology, Depertment of Haematology, Hospices Civils de Lyon and University, Lyon, France

++

MORTON COLEMAN, MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

++

MYRON STEFAN CZUCZMAN MD, Head, Lymphoma/Myeloma Service, Associate Professor of Medicine, Division of Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA

++

JULIE P. DEANS PhD, Associate Professor, AHFMR Senior Scholar Chair, Immunology Research Group, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada

++

JULIAN DECTER MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

++

NANCY DRISCOLL RPA-C, Division of Haematology and Oncology, Long Island Jewish Medical Center, New York, New York, USA

++

VIVIANE DUBRUILLE PhD, Doctor of Haematology, Hotel Dieu, University Hospital, Nantes, France

++

MARTIN J. S. DYER MA, DPhil, FRCP, FRCPath, Professor of Haemato-Oncology, MRC Toxicology Unit / Leicester University, Leicester, UK

++

CHRISTOS EMMANOUILIDES MD, Associate Professor, Division of Hematology and Oncology, UCLA, currently: Interbalkan European Medical Center-Oncology, Pylaia, Thessaloniki, Greece

++

RICHARD R. FURMAN MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

++

DAVID M. GOLDENBERG MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

++

LEO I. GORDON MD, Abby & John Friend Professor of Cancer Research, Chief, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago Ilinois, USA

++

TERRY J. HAMBLIN DM, FRCP, FRCPath, FMedSci, Professor of Immunohaematology, University of Southampton, Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK

++

JEAN-LUC HAROUSSEAU MD, Professor of Haematology, Hotel Dieu, University Hospital, Nantes, France

++

FRANCISCO J. HERNANDEZ-ILIZALITURRI MD, Assistant Professor of Medicine, Department of Medical Oncology. Member of the Tumor Immunology Program, Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA

++

PETER HILLMEN MRCP, MRCPath, PhD, Department of Haematology, Pinderfields Hospital, Wakefield, UK

++

IVAN D. HORAK MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

++

ANDREW JACK BSc, MB, ChB, PhD, Consultant Haematopathologist, Haematological Malignancy Diagnostic Service (HMDS), Leeds General Infirmary, Leeds, UK

++

ANDRZEJ J. JAKUBOWIAK MD, PhD, Assistant Professor of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA

++

DALE M. JANSON RPA-C, MBA, Division of Haematology and Oncology, Long Island Jewish Medical Center, New York, New York, USA

++

MARK S. KAMINSKI MD, Professor of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA

++

MICHAEL KEATING MD, Professor of Medicine, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

++

PETER MCLAUGHLIN MD, Professor of Medicine, Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

++

JOHN P. LEONARD MD, The Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, USA

++

THOMAS S. LIN MD, PhD, Assistant Professor of Internal Medicine, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio, USA

++

BLANCHE H. MAVROMATIS MD, Assistant Professor of Medicine, Lombardi Comprehensive Cancer Center, Washington, DC, USA

++

HĂ…KAN MELLSTEDT MD, PhD, Professor of Oncologic Biotherapy, Department of Oncology (Radiumhemmet), Karolinska University Hospital Solna, Stockholm, Sweden

++

SUSAN M. O'BRIEN MD, Professor, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

++

DILIP V. PATEL MD, Division of Haematology and Oncology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, Bronx, New York, New York, USA

++

KARL S. PEGGS BM, BCh, MA, MRCP, MRCPath, Senior Lecturer in Bone Marrow Transplantation, Department of Haematology, University College Hospital, Royal Free and University College London Medical School, London, UK

++

KANTI R. RAI MD, Chief, Division of Haematology and Oncology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, Bronx, New York, New York, USA

++

FARHAD RAVANDI MD, Assistant Professor of Medicine, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

++

NANCY LOU TUINSTRA RN, Mayo Clinic College of Medicine, Nuclear Medicine, Rochester, Minnesota, USA

++

WILLIAM A. WEGENER MD, Immunomedics, Inc., Morris Plains, New Jersey, USA

++

THOMAS E. WITZIG MD, Professor of Medicine, Division of Internal Medicine and Hematology, Mayo Clinic, Rochester, Minnesota, USA

++

KARENW. L. YEE MD, Fellow, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.